SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mary Cluney who wrote (96735)1/25/2005 2:28:56 PM
From: Lane3  Read Replies (3) of 793698
 

Just because somebody writes about this stuff, doesn't mean it has validity.

I imagine that what happened was as follows. They were doing a study on this new combination of older drugs. The results showed that it was not particularly effective, no better than the alternatives. But there was a silver lining in that they found that for one subgroup of their study, blacks, it was effective. Given that other drugs had been reported as less effective on blacks than on others, they got the idea that this new combination might warrant approval for this underserved group.

It seems to me that its utility would be another tool in the toolkit. If you've tried all the other heart meds without success and you have significant black ancestry, this new combination would be worth a try. It just might work. I doubt that it will be marketed as the drug of choice for the black race, whatever that may comprise.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News